Why BioRestorative Therapies Stock Is Moving Higher Thursday
Why BioRestorative Therapies Stock Is Moving Higher Thursday
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Thursday after the company said it has engaged in licensing discussions with a undisclosed commercial regenerative medicine company.
BioRestorative Therapies，Inc.（纳斯达克：BRTX）股票周四上涨，因该公司表示已经与一家未披露商业再生医学公司进行了许可讨论。
What Happened: BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions with an regenerative medicine company related to its ThermoStem Metabolic Disease Program intellectual property.
事件经过：BioRestorative Therapies周四市场开放之前宣布，该公司与一家再生医学公司就其ThermoStem代谢疾病方案知识产权进行了实质性授权讨论。
Research conducted in collaboration with the University of Utah School of Medicine has demonstrated that certain stem cells with brown adipogenic potential could represent a new way of treating obesity and related metabolic disorders.
与犹他州医学院合作的研究表明，具有褐色脂肪生成潜能的某些干细胞可能代表了治疗肥胖和相关代谢疾病的新途径。
Currently, there is no guarantee that a license agreement will be made between the two companies.
目前，两家公司之间有无许可协议的保证。
Related Link: Candel Therapeutics' (NASDAQ:CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
相关链接：Candel Therapeutics的（纳斯达克：CADL）enLIGHTEN Discovery平台旨在应对肿瘤微环境的复杂性。
BRTX Price Action: At the time of writing, BioRestorative shares are trading 29% higher at $1.75 per data from Benzinga Pro.
BRTX价格走势：截至撰稿时，BioRestorative股票交易上涨29％，股价为1.75美元，根据Benzinga Pro数据。
Image: Image via Shutterstock
图片：图片通过shutterstock获取。